Blood glucose consumables and EQA materials

Concepts

• blood testing reagents
• blood glucose consumables
• cardiff
• diabetes
• supply of blood glucose consumables
• blood glucose
• supply of blood glucose
• concentration of glucose
• blood
• consumables

Location

Central Valleys: CTM UHB region

Description

Supply of blood glucose consumables (testing strips) and EQA materials.

Total Quantity or Scope

Blood glucose monitoring refers to testing the concentration of glucose in the blood to aid the management of Diabetes types 1 & 2. Similarly, monitoring the presence of ketones in the blood is also important as high levels can result in complications such as Ketoacidosis. This procurement will involve the supply of Blood glucose monitoring equipment(meters) and associated consumables (Test-strips for the Point of Care Testing Service at Cwm Taf Morgannwg University Health Board. This will be to renew the existing arrangement with Abbott Laboratories Ltd.

Award Detail

CPV Codes

• 33696200 - Blood-testing reagents

Legal Justification

The current contract with Abbott Laboratories Ltd ended on the 30th of September 2021. The Health Board's intention was to enter into a new contract with Abbott Laboratories Ltd through a direct award under the terms of a Public Sector Framework. This would enable sufficient time for NWSSP Shared Services Procurement to undertake a formal market-test exercise, to award a new All Wales Framework. Currently, the Health Board's POCT Service is not able to contemplate an alternative supplier for the reasons outlined below: The migration of operators to a completely new device would need to be completed on a rolling basis with full training for every member of staff. The POCT Team is not in a position to support this due to the extra training demands in relation to Covid-19 and the clinical areas are still finding it difficult to release staff to attend training, due to staffing pressures. The current management of testing allows for staff to move flexibly from one area or site to another. During the process of migration, this flexibility will be lost to a degree with some areas using the new meter and other areas using the existing meter, this could expose the HB to risk, given current staffing pressures. The Health Board cannot find a Public Sector Framework with which to engage with Abbott Laboratories Ltd at this time and therefore, there is no opportunity to make a compliant direct award. For the reasons outlined above and to ensure continuity of service for patient care, the Health Board has no option but to enter into a 12-month agreement without any formal underpinning Framework arrangement.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at https://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=115133. (WA Ref:115133)